168results about How to "Guaranteed therapeutic effect" patented technology

The invention relates to a novel vibration physiotherapeutic apparatus which comprises a shell. A sliding plate is arranged inside the shell; a plurality of universal balls are arranged at the bottom end of the sliding plate; left and right sliding wheels are respectively arranged at both left and right sides of the sliding plate; the left and right sliding wheels are respectively embedded in left and right chute parts; the front side of the sliding plate is sequentially connected with first to fourth push rods from left to right, which are perpendicular to the sliding plate and extend forwards out of the shell; massaging balls are respectively arranged at the front ends of the first to fourth push rods; the first to fourth push rods positioned inside the shell are respectively sleeved with spiral springs; a motor and a rotating shaft are also respectively arranged inside the shell; the right end of the rotating shaft is connected with the motor by a coupling; the left end of the rotating shaft is connected with a left wall of the shell by a left bearing; at least two cams are also fixedly arranged on the rotating shaft; the cams are in contact with the rear side of the sliding plate and are pressed against the rear side of the sliding plate. By adopting the structure, the novel vibration physiotherapeutic apparatus can more effectively carry out vibrating massaging on a human body, so that a physiotherapeutic effect of the novel vibration physiotherapeutic apparatus is greatly ensured.

The invention discloses an automatic temperature control moxibustion instrument. The moxibustion instrument is composed of a support, a moxa stick position adjusting device and a temperature sensor. The moxa stick position adjusting device and the temperature sensor are arranged on the support. The temperature sensor is in electric connection with the moxa stick position adjusting device. A moxa stick is arranged on the moxa stick position adjusting device. The temperature sensor is arranged to be close to a combustion portion of the moxa stick. The moxa stick position adjusting device is used for adjusting relative positions of the moxa stick and the temperature sensor according to readings of the temperature sensor. The automatic temperature control moxibustion instrument and a control method of the automatic temperature control moxibustion instrument have the advantages that the instrument can automatically carry out moxibustion treatment, labor intensity of medical staff is reduced, control flexibility is high, the artificial treatment technique can be highly simulated and the treatment effect can be ensured.

The invention belongs to the technical field of communication, and provides a medicine taking monitoring method. The medicine taking monitoring method includes the steps that a communication terminal sets medicine taking reminding time and a verification time threshold value; when current time reaches the medicine taking reminding time, the communication terminal carries out medicine taking reminding; the communication terminal judges whether medicine taking verification information is received or not within the verification time threshold value; if the medicine taking verification information is not received within the verification time threshold value, the communication terminal sends reminding information for a medicine taking failure to a preset monitoring terminal. Accordingly, the invention further provides a medicine taking monitoring system. In this way, the communication terminal is fully used for achieving the medicine taking monitoring function conveniently and sending the reminding information for the medicine taking failure to the monitoring terminal when judging out the medicine taking failure of a patient, and therefore a guardian of the patient can obtain the medicine taking conditions of the patient in time and take corresponding measures.

The invention discloses a multifunctional automatic moxibustion system based on an O2O health physiotherapy. The system comprises a base, a controller, a support, an adjustment device, a plurality of moxibustion stick fixing devices and a gas collecting device, wherein the base is used for supporting the automatic moxibustion system; the controller is used for transmitting control signals to the adjustment device so as to control movement of the adjustment device; the support is arranged above the base and used for adjusting the height and the direction of the automatic moxibustion system; the adjustment device is used for adjusting movement in the horizontal direction and the vertical direction of the moxibustion stick fixing devices and rotation of the moxibustion stick fixing devices according to control signals transmitted by the controller; the multiple moxibustion stick fixing devices are distributed below the adjustment device and used for fixing moxibustion sticks; and the gas collecting device is arranged on the outer sides of the moxibustion stick fixing devices in a surrounding mode and used for discharging gas generated by moxibustion stick burning. The invention further provides a moxibustion method. According to the scheme, four moxibustion methods of the moxibustion sticks can be achieved at the same time; in addition, the height of the moxibustion sticks can be adjusted, and the moxibustion treatment effect is guaranteed.

A composite suppository for treating pile, phlebitis and phlebeurysma is prepared from micro-granular diosmin and hesperidin, matrix for suppository and additive.

The present invention discloses a radiotherapy radiation device and radiation method, which comprises source body(2), pre-collimate body(4), helmet(7), drive assembly and therapeutic bed(12), inside of the source body(2), multiple radiation source focuses ray along radial direction on a public focus on the center axis of radiation device, and the source body(2) and pre-collimate body are connected with drive assembly separately. The radiation method adopts system initiation, which enables the pre-collimate body(4) and helmet(7) to go through the steps of initial zero position, position locating and jointing end to end to implement radiotherapy. The advantages of which lie in the high focusing accuracy of the radiation source(3) and favorable therapeutic effect.

The invention claims protection for an arctigenin sublingual preparation and a use of the arctigenin sublingual preparation in the preparation of a medicine for treating a disease, and belongs to the field of medicines. According to the arctigenin sublingual preparation provided by the invention, a biological viscous material and an absorption promoter are added to effectively improve the absorption characteristic of the arctigenin sublingual preparation. When the arctigenin sublingual preparation provided by the invention is applied to treating a tumor, the tumor inhibition ratio of the medicine can be obviously improved, and the survival rate of a patient can be improved. The arctigenin sublingual preparation provided by the invention is high in biological availability, the treatment compliance of the patient can be improved, and therefore the arctigenin sublingual preparation has a good medical application prospect.

The present invention relates to an arasaponin oral disintegrant tablet and its preparation method. Its composition includes (by weight portion) 2-60 portions of arasaponin, 1-20 portions of disintegrant and 2-100 portions of filling agent.

The invention relates to a moxibustion therapeutic apparatus. The moxibustion therapeutic apparatus has the beneficial effects that the moxibustion therapeutic apparatus comprises a box; an opening is formed in the top surface of the box; a wind board is arranged at the opening; moxa insertion holes are formed in the bottom surface of the box; moxa stick sleeves used for placing moxa sticks penetrate through the moxa insertion holes; a plurality of heat adjusting holes are formed in the side of the box; accordingly, the moxibustion therapeutic apparatus can be suitable for large area moxibustion therapy, is accurate in determining acupoints at fixed points and convenient in adjustment and accurate control of temperature and is safe and reliable; further, a smoke vent is formed in the side of the box and a smoke discharge pipe is connected with the smoke vent and comprises an adjustable hose and a length adjustable smoke discharge support pipe connected with one end of the adjustable hose, thus forming s moxa smoke channel to effectively discharge moxa smoke.

The invention discloses a rectal drug administration device for the gastroenterology department and with an electric adjusting function. The device comprises a cylinder with a hollow interior, the cylinder is composed of a spherical structure at the front end and a cylindrical structure at the rear end, a clapboard is sealably and fixedly connected between the spherical structure and the cylindrical structure, a drug administration pipe is slidably connected to the center of the clapboard in a penetrating mode, the end, away from the spherical structure, of the drug administration pipe extendsto the exterior of the cylindrical structure in a penetrating mode, and multiple drug outlet holes which are used in cooperation with the drug administration pipe are formed in the surface of the spherical structure of the front end of the cylinder. According to the device, when rectal drug delivery is conducted, the interior of the anus of a patient can be expanded, a drug administration instrument is assisted in being successfully pushed to the intestinal canal, thus a drug in the drug administration pipe can be conveyed to the part of the intestinal canal, and the therapeutic effect on thepatient can be guaranteed; meanwhile, when the rectal drug administration device conducts drug delivery on the patient multiple times, the drug administration instrument does not need to be repeatedly stretched into the body of the patient, the pain of the patient is smaller, the drug administration efficiency is higher, and the time and energy of medical personnel are saved to a great extent.

The invention discloses a drug balloon. The drug balloon comprises a balloon body and a drug coating located on the surface of the balloon body, wherein the drug coating comprises a drug and an excipient; the drug coating comprises a near-end coating, a middle-section coating and a far-end coating, the drug-loading density of one of the near-end coating and the far-end coating is larger than the drug-loading density of the middle-section coating, and the drug-loading density of the other one of the near-end coating and the far-end coating is not smaller than the drug-loading density of the middle-section coating. When stent restenosis lesions are treated, the drug balloon is selected to be pressurized according to lesion characteristics, the drug balloon has a supporting function, part ofthe coating with a large drug-loading density is close to severe stenosis lesions at the near end or the far end, the drug content is selectively increased, and the stenosis rate of severe lesion areais reduced; meanwhile, the total drug content of the whole lesions is reduced, and the drug toxicity and adverse reactions of the body are reduced.

The invention relates to novel medical application of anhydroicaritin, particularly to application of anhydroicaritin in preparing a drug for treating or preventing thrombopenia, and belongs to the field of medicines. In order to overcome the technical defects that, in the prior art, the thrombopenia therapeutic drug is unabiding in therapeutic effect, high in possibility of recidivation during drug discontinuance and high in side effect, the invention provides a therapeutic drug containing anhydroicaritin. The therapeutic drug can greatly improve the platelet level of a parent when being used for treating thrombopenia, particularly immune thrombopenia, and has an obvious therapeutic effect; the therapeutic drug further has the obvious therapeutic effect on treating thrombopenia caused by myelosuppression; when being used for treating thrombopenia, anhydroicaritin has the advantages of being obvious in curative effect, low in treatment cost and little in toxic and side effects, and the therapeutic drug is quite suitable for clinical popularization and application.

The invention relates to the field of dressing auxiliary therapy, in particular to a cold-compress dressing and dressing paste containing the cold-compress dressing. The cold-compress dressing is prepared from the following components in parts by mass: 250-300 parts of a gel matrix, 50-100 parts of ionized water, 20-50 parts of medicinal alcohol, and 30-70 parts of traditional Chinese medicine powder. The unique traditional Chinese medicine powder is added to the cold-compress dressing, so that blood activating and stasis dispersing to a disease part can be effectively cooperatively realized,and meanwhile, ice-cold feeling can be brought to the disease part, and pain is alleviated; after a liquid medicine is injected through a drainage short pipe, a blocking stopper is closed, so that medicine permeation can be further effectively improved, and the therapeutic effect is guaranteed; while the medicine enters, the medicine can be transitorily stored in a sucker cavity, so that a contactarea between the liquid medicine and the skin disease part is increased, and medicine permeation efficiency is improved; and while the cold-compress dressing is prepared, the medicinal alcohol is added after cooling, so that high-temperature volatilization of the medicinal alcohol can be effectively reduced, permeability of the alcohol in the dressing is improved, and the heat-absorbing effect ofthe cold-compress dressing in later use is guaranteed.

The invention provides Lacidipine dispersible tablets, which are medicines for treating hypertension, and a preparation method thereof. The Lacidipine dispersible tablets contain an effective amount of Lacidipine and pharmaceutical auxiliary materials. The auxiliary materials comprise polyethylene glycol, a diluent, a disintegrating agent, a lubricant and a flow aid. In the preparation process of the Lacidipine dispersible tablets, the polyethylene glycol is introduced as a medicine dispersion medium, the Lacidipine is formed into solid dispersion first and then mixed uniformly with other auxiliary materials, and the mixture is tabletted to form the disperse tablets. Compared with the common tablets, the Lacidipine dispersible tablets have the advantages of optimal dispersion state, short disintegrating time, quick medicine dissolution and the like. The Lacidipine dispersible tablets can be taken conveniently, the preparation process of the Lacidipine dispersible tablets is simple, special requirements on materials and equipment are avoided, and the industrial production can be realized easily.

The present invention relates to the medical technology field, and provides a movement detection system. The system comprises a controller, a displacement calculation module, a position sensor and an alarm module. The position sensor is fixedly arranged on a target object and configured to record the position of the target object and send position data to the displacement calculation module; the displacement calculation module is connected with the position sensor and the controller and configured to receive the position data transmitted by the position sensor, calculate the displacement and transmit the displacement data to the controller; and the controller connected with the displacement calculation module and the alarm module and configured to perform comparison analysis of the received displacement data and theoretical data and send control signals to the alarm module; and the alarm module connected with the controller and configured to receive the control signals of the controller and perform execution. The movement detection system and method greatly improve the movement precision of a mobile treatment bed and other medical devices and ensure the patients' treatment effect to the greatest extent.

The invention discloses a 3D doctor-patient interactive demonstration method for the occurrence, development and therapeutic methods of diseases, possible prognosis and cost to ensure that the patients or the families can have right to know. The method comprises the following steps: receiving instruction data; obtaining demonstration rule data from a rule database and obtaining 3D model sample data from a material library according to the instruction data; and generating 3D demonstration data according to the demonstration rule data and the corresponding 3D model sample data and sending the 3D demonstration data to a demonstration terminal. Correspondingly, the invention provides a doctor-patient interactive demonstration system. On one hand, according to the method and system, the whole medical treatment processes which are difficult to understand by languages are statically or dynamically demonstrated to the patients or the families through plain, simple and straight three-dimensional and four-dimensional pictures, so that the doctor-patient communication is realized, doctor-patient disputes are decreased and a doctor-patient communication standardized flow for the medical workers is established. On the other hand, according to the method and system, more precise data models can be provided for the clinic teaching and researching.

The invention provides an induction method of callus of a sterile seedling prepared from the root bud of Amomum villosum Lour. The induction method comprises the following steps: taking the sterile seedling of the root bud of the Amomum villosum Lour. as an explant, sterilizing, inoculating and performing induction culture to obtain the callus, wherein an induction medium for induction culture isMS+1.0 to 2.5 mg/L 6-BA+0.5 to 1.5 mg/L 2,4-D+0.5 to 1.5 mg/L NAA; the illumination time of a culture environment is 10 h, the light intensity is 2000 Lx, and the culture temperature is 25 DEG C. Thestem and the root tip of the sterile seedling of the rhizome of the Amomum villosum Lour. Are used as the explant, and the asexual reproduction can retain the complete medicinal properties of a parent, and variation is not easy to generate, thereby making the medicine property stable and ensuring the effect of the drug treatment, and the explant material is easy to obtain and can be taken at any time for breeding culture.

The invention discloses a TPE material for medical infusion device tube and a preparation method thereof. The TPE materials includes the following raw materials by weight: 100 portions of SEBS, 30 portions of co-polypropylene, 20 portions of oleamide and 1 portion of an antioxidant. The medical infusion device tube prepared from the TPE material has no adsorption effect on many drugs, so that drug dosage accuracy and the therapeutic effect are guaranteed; and the problem of participation of released paclitaxel injection and the polyoxyethylene castor oil in plasticizing agent in the reaction are avoided, so as to ensure the use effect of anti-cancer drug such as paclitaxel. In addition, the medical infusion device tube can avoid the problem of migration of processing aid or plasticizer into the blood or in medical liquid, and the important indexes including pH value variation, reducing substances, heavy metal content, cell toxicity, UV absorbance, sensitization response and hemolytic reaction are superior to those of the similar polyvinyl chloride products, so as to ensure the safety of patients.

The invention belongs to the field of pharmaceutical preparations, and particularly relates to a preparation method of an immediate release oral preparation containing sitagliptin or sitagliptin pharmaceutical salt. The immediate release oral preparation is characterized in that in a preparation process of the immediate release oral preparation, when sitagliptin or sitagliptin pharmaceutical salt is in a hydrate crystal form, a wetting agent is water, and when sitagliptin or sitagliptin pharmaceutical salt is in an anhydrous crystal form, the wetting agent is ethanol. According to the preparation method, various technical features in the preparation method supplement each other, influence each other and synergistically act, and the crystal form of an active ingredient is not transformed before and after the preparation is prepared, so that the treatment effect is ensured; in addition, the compressibility of a material is improved significantly; the disintegration time is shortened obviously; and the problem of sticking is solved effectively.

The invention provides a medical intelligent medicine box system which comprises a lithium storage battery, a key power supply switch, a charging socket, a medicine box, medicine bottles, a weight detection circuit, a signal sending control circuit, a signal sending circuit, a timing circuit, a counting reminding circuit, an information receiving unit, an information comparison unit and an information pushing unit, wherein the information receiving unit, the information comparison unit and the information pushing unit are application software installed in mobile phones of doctors, patients andfamily members of the patients; the lithium storage battery, the key power supply switch, the charging socket, the quality detection circuit, the signal sending control circuit, the signal sending circuit, the timing circuit and the counting reminding circuit are arranged in the medicine box; and the medicine bottles are arranged in the medicine box. When the patient does not take medicine, reminding can be given to the patient in time; the treatment effect of the medicine taken by the patient is ensured; the doctor can favorably determine the treatment effect of a recipe; and after the medicine is out of date, the patient is reminded of not taking the medicine, so that the influence caused on body health when the patient innocently takes medicine which is out of date is avoided.

The invention belongs to the medicine preparation field and discloses a method for preparing Dandeng Tongnao pharmaceutical preparation and a quality control method. The preparation method is as follows: firstly, volatile oil extracted from hemlock parsley is standby or cladded and then residue and kudzu root are extracted water and precipitated alcohol, filtered and concentrated into concentrated solution A; secondly, Salvia miltiorrhiza and Erigeron breviscapus are extracted alcohol, filtered and concentrated into concentrated solution B; thirdly, the concentrated solution A and the concentrated solution B are mixed, concentrated into thick paste and then dried and crushed; volatile oil clathrate powder is added into the mixture, and extracted dry medicinal powder is obtained; fourthly, or the concentrated solution A and the concentrated solution B are mixed; the standby volatile oil is added into the mixture which is then uniformly mixed and filtered, and extracted liquid medicine is obtained; fifthly, the corresponding pharmaceutical preparation is prepared by addition of auxiliary materials which can be accepted pharmaceutically by the extracted dry medicinal powder or the extracted liquid medicine. The quality control method comprises the following steps of content test and content discrimination, wherein, the content test takes puerarin and tanshinone II A as the index, and the content discrimination takes hemlock parsley contrast medicine, puerarin and scutellarin as the contrast. The method is simple in preparation technique and short in production period and is suitable for industrial production; and the quality control method comprehensively guarantees the product quality.

The invention discloses a veterinary-use intestinal targeted antibacterial pellet. The veterinary-use intestinal targeted antibacterial pellet comprises a main drug and auxiliary drugs, wherein the main drug is composed of valnemulin hydrochloride and chlortetracycline hydrochloride; the mass of the valnemulin hydrochloride is 1-5% of that of the pellet; the mass of the chlortetracycline hydrochloride is 5-16 times of that of the valnemulin hydrochloride; the pellet sequentially comprises a valnemulin hydrochloride core, an intestinal targeted coating layer, a chlortetracycline hydrochloride drug layer and an outer coating layer from inside to outside. The invention further discloses a preparation method of the veterinary-use intestinal targeted antibacterial pellet. Through the combination of the method and the formula, the valnemulin hydrochloride and the chlortetracycline hydrochloride are adopted for preparing the pellet; the pellet is released in a gradient form in an animal digestion system; the chlortetracycline hydrochloride is firstly released and absorbed by the stomach and the intestine; the valnemulin hydrochloride is rapidly released and absorbed by the intestinal tract with the pH value larger than or equal to 6.8, so that an excellent intestinal tract sterilization effect is achieved, the drug absorbed by the colon can be prevented from suffering from the first-pass effect of the liver and the intestine, the haemoconcentration and bioavailability of the valnemulin hydrochloride can be improved, and an excellent treatment effect for systemic diseases is obtained.

The invention discloses a developing foam hardening agent for treating venous malformations. The developing foam hardening agent comprises two effective ingredients, namely, polycinnamyl alcohol and ultravist, in a volume ratio of 2:1. A preparation method of the developing foam hardening agent specifically comprises the following steps of: extracting the polycinnamyl alcohol and the ultravist using by using a syringe according to a formula ratio, shaking and mixing up uniformly, extracting sterile air by using another syringe, connecting the two syringes by using a medicinal three-way valve, and injecting front and back for multiple times according to a Tessari method so as to mix the polycinnamyl alcohol and the ultravist into uniform and stable foams, wherein the volume ratio of the polycinnamyl alcohol to the sterile air is 1:4. According to the preparation method, a hardening agent, namely, a polycinnamyl alcohol injection, and a contrast agent, namely, the ultravist, are mixed up according to appropriate ratio and prepared into a foam hardening agent, the foam hardening agent is more stable when being compared with a hardening agent which is prepared from polycinnamyl alcohol and air merely, and the foam hardening agent is injected into venous malformation lesion in a partial puncture mode under the mediation of DSA (Digital Subtraction Angiography), so that precision, visualization and idealization in a curative effect are achieved.

The invention provides ultrasonic treatment equipment. The ultrasonic treatment equipment comprises an ultrasonic transduction transmitter, an ultrasonic transduction receiver, a judgment device and a feedback control device, wherein an ultrasonic transduction transmitter is used for generating and transmitting ultrasonic wave to an active area, an ultrasonic transduction receiver is used for collecting sound signals from the active area and converting the collected sound signals into electric signals, a judgment device is used for judging whether the active area has an acoustic cavitation in a preset strength range to acquire a judgment result, and a feedback control device is used for controlling the ultrasonic transmission dosage of the ultrasonic transduction transmitter when the judgment result indicates that the acoustic cavitation of the active area is not in the preset strength range, so that the acoustic cavitation of the active area is in the preset strength range. According to the ultrasonic treatment equipment, the accuracy of ultrasonic acoustic cavitation control means is improved, and the treatment effect is ensured.

The invention discloses an illumination medical device and a method using same, and belongs to the field of medical devices. The illumination medical device includes: an illumination medical device main body, a light source and a light switch element which are arranged on the illumination medical device main body, and an image identification module which is in signal connection to the light switch element. According to the invention, the image identification module identifies the contour of a to-be-treated area and provides the contour to the light switch element, the light switch element, based on the contour of the to-be-treated area provided by the image identification module, controls the contour of a radiation area on the to-be-treated area radiated by the light source to match the contour of the to-be-treated area, such that when the illumination medical device provided by the invention treats a skin disease, the contour of the radiation area on the to-be-treated area radiated by the light source can overlap the contour of the to-be-treated area. The device and the method guarantee treatment effects of the to-be-treated area and can at the same time avoid damage to the skin of healthy area.

The invention relates to an annular pulmonary artery stimulation ablation catheter which comprises a catheter body, a mesh basket, an ablation treatment unit, and a blood pressure monitoring unit, wherein a driving handle is movably installed on the catheter body; the mesh basket is movably arranged on the catheter body and connected with the driving handle, and the mesh basket has a contraction state for avoiding a pulmonary artery opening and an expansion state for being tightly attached to the pulmonary artery opening; the ablation treatment unit is arranged on the catheter body and connected with the mesh basket; and the blood pressure monitoring unit is arranged on the tube body. After a part needing to be ablated is positioned, the ablation treatment unit is started, and then stimulation ablation treatment can be completed; and then the blood pressure changes of the part needing to be ablated are monitored again, and whether ablation takes effect or not can be further judged until the whole circular pulmonary artery ablation treatment operation is completed. Compared with a traditional ablation catheter, the annular pulmonary artery stimulation ablation catheter in the schemecan accurately position the part needing to be ablated through blood pressure monitoring, and the annular pulmonary artery ablation treatment effect and efficiency are greatly improved.

The invention discloses a simple burn patient elastic garment pressure tester comprising a storage box, a first exhaust hole, a first spring, a slide plate, a connecting rod, a liquid discharge slot,an exhaust pipe, an air cushion, an air bag, a placing box, a connector, a second spring and slide blocks. The simple burn patient elastic garment pressure tester is ingenious in structure, powerful in function and easy to operate. With application of the device, the pressure of the elastic garment can be tested and the concrete situation of the pressure of the elastic garment can be known by themedical personnel so that the medical personnel is enabled to perform corresponding adjustment processing of the pressure of the elastic garment and the treatment effect of the patient can be ensured.

The invention provides a rotary physiotherapy cabin comprising a cabin body, a cabin rotating power device, physical field releasing devices and a net bed. An output end of the cabin rotating power device is connected to a rotating end of the cabin body, the net bed extends into the interior of the cabin body, and the inner wall of the cabin body is symmetrically provided with one or more pairs ofphysical field release devices. Each of the physical field release devices is a piece or a combination of one or two or more different physical field emitters in a group consisting of a treatment plate of a TDP therapeutic device, an infrared emitter, a spectrum generator, a microwave transmitter, a special light wave emitter, a conventional light quantum generator, a quantum shaped integrated core block, a permanent magnet and an energized coil. According to the rotary physiotherapy cabin, a condition of the rotational coupling of multiple physical fields is achieved, and a multi-physical-field coupling effect is introduced to the physical therapy or treatment of human diseases for the first time. The rotary physiotherapy cabin has the advantages of a reasonable structural design, the easy grasp of an application method and easy promotion and is particularly suitable for the physical therapy or treatment of chronic systemic diseases.

The invention discloses a mixture for a disposable medical infusion product. The mixture is prepared from the following materials in parts by weight: 100 parts of TPE (thermoplastic elastomer), 20 to45 parts of polypropylene, and 0.1 to 2.5 parts of an antioxidant, wherein the TPE is a hydrogenated block polymer formed by hydrogenating an S1-b-B/I-b-S2 block polymer; the hydrogenation degree of aB/I block is higher than or equal to 80%; in the S1-b-B/I-b-S2 block polymer, S1 and S2 are styrene blocks; B/I is a butadiene and isoprene random copolymerization block; the weight ratio of the styrene blocks to the butadiene and isoprene random copolymerization block (B/I) is 10/90-30/70; an isoprene unit accounts for 5 to 30 weight% of the S1-b-B/I-b-S2 block polymer; the weight content of the1,2- structure of the isoprene unit is 45 to 85%. The hydrogenated block polymer under the content of the isoprene unit and the weight content of the 1,2- structure is mixed with PP (polypropylene),thus contributing improvement of the defects of cracking and relatively low elasticity of the prepared medical infusion product.

The external medicine for treating vitiligo of the present invention is composed of A ointment and B liniment. The medicament of the present invention is different from the previous treatment scheme of simply treating vitiligo, and pioneered the "day and night double cycle therapy", which is administered continuously for 24 hours. Use A ointment at night to change the epidermal tissue structure of surface infection lesions, which is conducive to the smooth penetration of the drug and directly reach the lesion tissue, rapidly increase the activity of skin melanocytes, activate tyrosinase to accelerate melanin synthesis; use B liniment during the day to supplement various Active ingredients and trace elements can increase photosensitivity and promote melanin production, quickly and completely eliminate the pathogenic factors of vitiligo, increase the function of melanocytes and protect the accumulation of melanin in the skin to achieve the effect of non-recurrence. Multi-level and three-dimensional, prevention and treatment, symptoms and root causes are treated at the same time, the treatment method is unique, and the curative effect is reliable.